After 7 years in stealth, UC Berkeley spinout Nodexus emerges with an RA Capital-backed Series A

A new company emerged from stealth this morning in San Francisco Bay, and it’s one focused on research technology.

Nodexus, a bio company that develops automated live cell characterization and isolation technologies, announced its launch this morning with a Series A netting it $30 million.


Click to view original post